MRL/MpJ-Tnfrsf6lpr(MRL/lpr) mice, a murine model of systemic lupus erythematosus (SLE), have defective expression of Fas, substantially reducing signaling for apoptosis via this mechanism. However, it is known that MRL//pr mice have increased spontaneous apoptosis of leukocytes. These conflicting observations have stimulated interest in apoptosis in this SLE model. MRL/lpr mice overproduce nitric oxide (NO) as autoimmune disease progresses. In vitro administration of NO may induce or decrease apoptosis depending on the cell type. Therefore, we hypothesized that NO induces MRL/lpr spleen lymphocyte apoptosis independent of Fas receptor engagement.
Methods
Percentages of apoptotic spleen lymphocytes from MRL/lpr and BALB/cJ mice were determined ex vivo after in vivo treatment with NG-monomethyl-l-arginine (NMMA), a nitric oxide synthase (NOS) inhibitor. After culture in varying concentrations of a slow-acting NO donor, the following were determined in spleen lymphocytes: (1) levels of apoptosis, (2) the effect of phorbol myristate acid (PMA) on levels of NO-induced apoptosis, and (3) protein kinase C (PKC) activity.
Results
Spleen lymphocytes from MRL/lpr mice with active disease had increased levels of ex vivo apoptosis when compared with BALB/cJ controls. This increase was reduced by pharmacologic inhibition of NOS in MRL/lpr but not in BALB/cJ mice. Exogenous administration of NO in vitro reduced PKC activity and induced apoptosis in MRL/lpr spleen lymphocytes, an effect that could be reduced via coadministration of PMA in vitro.
Conclusion
These results suggest that NO plays a role in spleen lymphocyte apoptosis in MRL/lpr mice, possibly via inhibition of PKC, despite a Fas defect.
MarianiS.M., MatibaB., ArmandolaE.A., KrammerP.H.The APO-1/Fas (CD95) receptor is expressed in homozygous MRL/lpr mice.Eur J Immunol1994; 24: 3119–23.
2.
SinghA.K.Lupus in the Fas lane?J R Coll Phys Lond1995; 29: 475–8.
3.
BossuP., SingerG.G., AndresP.Mature CD4+ T lymphocytes from MRL/lpr mice are resistant to receptor-mediated tolerance and apoptosis.J Immunol1993; 151: 7233–9.
4.
Van HoutenN., BuddR.C.Accelerated programmed cell death of MRL-lpr/lpr T lymphocytes.J Immunol1992; 149: 2513–7.
5.
WeinbergJ.B., GrangerD.L., PisetskyD.S.The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-l-arginine.J Exp Med1994; 179: 651–60.
6.
OatesJ.C., RuizP., AlexanderA.Effect of late modulation of nitric oxide production on murine lupus.Clin Immunol Immunopathol1997; 83: 86–92.
MillsC.D., StevensR.B., SutherlandD.E.Nitric oxide in autoimmunity and cell transplantation.Transplant Proc1994; 26: 3348.
9.
FarrellA.J., BlakeD.R., PalmerR.M., MoncadaS.Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases.Ann Rheum Dis1992; 51: 1219–22.
10.
MclnnesI.B., LeungB.P., FieldM.Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients.I Exp Med1996; 184: 1519–24.
11.
St ClairE.W., WilkinsonW.E., LangT.Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients.J Exp Med1996; 184: 1173–8.
12.
ShimaokaM., IidaT., OharaA.NOC, a nitric-oxide-releasing compound, induces dose dependent apoptosis in macrophages.Biochem Biophys Res Commun1995; 209: 519–26.
13.
KitajimaI., KawaharaK., NakajimaT.Nitric oxide-mediated apoptosis in murine mastocytoma.Biochem Biophys Res Commun1994; 204: 244–51.
14.
CuiS., ReichnerJ.S., MateoR.B., AlbinaJ.E.Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms.Cancer Res1994; 54: 2462–7.
15.
AnkarcronaM., DypbuktJ.M., BruneB., NicoteraP.Interleukin-1 beta–induced nitric oxide production activates apoptosis in pancreatic RINm5F cells.Exp Cell Res1994; 213: 172–7.
GenaroA.M., HortelanoS., AlvarezA.Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels.J Clin Invest1995; 95: 1884–90.
BeauvaisF., MichelL., DubertretL.The nitric oxide donors, azide and hydroxylamine, inhibit the programmed cell death of cytokine-deprived human eosinophils.FEBS Lett1995; 361: 229–32.
21.
MannickJ.B., AsanoK., IzumiK.Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation.Cell1994; 79: 1137–46.
22.
ReillyC.M., FarrellyL.W., VitiD.Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase.Kidney Int2002; 61: 839–46.
GrangerD.L., TaintorR.R., BoockvarK.S., HibbsJ.B.JrMeasurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction.Methods Enzymol1996; 268: 142–51.
25.
KoopmanG., ReutelingspergerC.P., KuijtenG.A.Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis.Blood1994; 84: 1415–20.
26.
VermesI., HaanenC., Steffens-NakkenH., ReutelingspergerC.A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled annexin V.J Immunol Methods1995; 184: 39–51.
27.
DarzynkiewiczZ., BrunoS., Del BinoG.Features of apoptotic cells measured by flow cytometry.Cytometry1992; 13: 795–808.
28.
WatsonM.L., RaoJ.K., GilkesonG.S.Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci.J Exp Med1992; 176: 1645–56.
29.
MusetteP., PannetierC., GachelinG., KourilskyP.The expansion of a CD4+ T cell population bearing a distinctive beta chain in MRL lpr/lpr mice suggests a role for the fas protein in peripheral T cell selection.Eur J Immunol1994; 24: 2761–6.
30.
EmlenW., NieburJ., KaderaR.Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus.J Immunol1994; 152: 3685–92.
31.
RichardsonB.C., YungR.L., JohnsonK.J.Monocyte apoptosis in patients with active lupus.Arthritis Rheum1996; 39: 1432–4.
32.
CourtneyP.A., CrockardA.D., WilliamsonK.Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia.Ann Rheum Dis1999; 58: 309–14.
33.
PerniokA., WedekindF., HerrmannM.High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus.Lupus1998; 7: 113–8.
34.
ChanE.Y., KoS.C., LauC.S.Increased rate of apoptosis and decreased expression of bcl-2 protein in peripheral blood lymphocytes from patients with active systemic lupus erythematosus.Asian Pac J Allergy Immunol1997; 15: 3–7.
35.
LorenzH.M., GrunkeM., HieronymusT.In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases.Arthritis Rheum1997; 40: 306–17.
36.
KanaiY., KyuwaS., MiuraK., KurosawaY.Induction and natural occurrence of serum nucleosomal DNA in autoimmune MRL/lpr/lpr mice: its relation to apoptosis in the thymus.Immunol Lett1995; 46: 207–14.
LichtR., van BruggenM.C., Oppers-WalgreenB.Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolysaccharide administration.Arthritis Rheum2001; 44: 1320–30.
WangB., DongX., YuanZ.SSA/Ro antigen expressed on membrane of UVB-induced apoptotic keratinocytes is pathogenic but not detectable in supernatant of cell culture.Chin Med) (Engl)1999; 112: 512–5.
41.
Casciola-RosenL.A., AnhaltG., RosenA.Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes.J Exp Med1994; 179: 1317–30.
42.
RosenA., Casciola-RosenL.Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease.Cell Death Differ1999; 6: 6–12.
43.
TakeokaY., TaguchiN., ShultzL.Apoptosis and the thymic microenvironment in murine lupus.J Autoimmun1999; 13: 325–34.
44.
RavirajanC.T., SarrafC.E., AnilkumarT.V.An analysis of apoptosis in lymphoid organs and lupus disease in murine systemic lupus erythematosus (SLE).Clin Exp Immunol1996; 105: 306–12.
45.
NoelP.J., BoiseL.H., ThompsonC.B.Regulation of T cell activation by CD28 and CTLA4.Adv Exp Med Biol1996; 406: 209–17.
46.
GribbenJ.G., FreemanG.J., BoussiotisV.A.CTLA4 mediates antigen-specific apoptosis of human T cells.Proc Natl Acad Sci U S A1995, 92: 811–5.
47.
LucasM., Sanchez-MargaletV.Protein kinase C involvement in apoptosis.Gen Pharmacol1995; 26: 881–7.
48.
PotterP.K., Cortes-HernandezJ., QuartierP.Lupus-prone mice have an abnormal response to thioglycolate and an impaired clearance of apoptotic cells.J Immunol2003; 170: 3223–32.
49.
MitchellD.A., PickeringM.C., WarrenJ.C1q deficiency and autoimmunity: the effects of genetic background on disease expression.J Immunol2002; 168: 2538–43.
50.
LaderachD., BachJ.F., KoutouzovS.Nucleosomes inhibit phagocytosis of apoptotic thymocytes by peritoneal macrophages from MRL+/+ lupus-prone mice.J Leukoc Biol1998; 64: 774–80.
51.
BoydC.S., CadenasE.Nitric oxide and cell signaling pathways in mitochondrial-dependent apoptosis.Biol Chem2002; 383: 411–23.
52.
MoulianN., TruffaultF., Gaudry-TalarmainY.M.In vivo and in vitro apoptosis of human thymocytes are associated with nitrotyrosine formation.Blood2001; 97: 3521–30.
53.
BustamanteJ., BersierG., RomeroM.Nitric oxide production and mitochondrial dysfunction during rat thymocyte apoptosis.Arch Biochem Biophys2000; 376: 239–47.
54.
BustamanteJ., BersierG., BadinR.A.Sequential NO production by mitochondria and endoplasmic reticulum during induced apoptosis.Nitric Oxide2002; 6: 333–41.
55.
TaiX.G., Toyo-okaK., YamamotoN.Expression of an inducible type of nitric oxide (NO) synthase in the thymus and involvement of NO in deletion of TCR-stimulated double-positive thymocytes.J Immunol1997; 158: 4696–703.
56.
LuL., BonhamC.A., ChambersF.G.Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis.J Immunol1996; 157: 3577–86.
MozartM., ScuderiR., CelsingF., Aguilar-SantelisesM.Nitric oxide induces apoptosis in NALM-6, a leukaemia cell line with low cyclin E protein levels.Cell Prolif2001; 34: 369–78.
62.
MessmerU.K., LapetinaE.G., BruneB.Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds.Mol Pharmacol1995; 47: 757–65.
63.
JunC.D., OhC.D., KwakH.J.Overexpression of protein kinase C isoforms protects RAW 264.7 macrophages from nitric oxide-induced apoptosis: involvement of c-Jun N-terminal kinase/stress-activated protein kinase, p38 kinase, and CPP-32 protease pathways.J Immunol1999; 162: 3395–401.
64.
RifkinI.R., ChannavajhalaP.L., KieferH.L.Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.J Immunol1998; 161: 5164–70.
65.
OhkusuK., IsobeK., HidakaH., NakashimaI.Elucidation of the protein kinase C-dependent apoptosis pathway in distinct subsets of T lymphocytes in MRL-lpr/lpr mice.Eur J Immunol1995; 25: 3180–6.
